<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Prostamax: what changed | Grey Peptides</title>
    <link>https://greypeptides.com/changes/#e-prostamax</link>
    <atom:link href="https://greypeptides.com/changes/prostamax.xml" rel="self" type="application/rss+xml" />
    <description>News, regulatory alerts, corrections and new guides about Prostamax on Grey Peptides, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 30 Oct 2026 12:00:00 +0000</lastBuildDate>
    <ttl>1440</ttl>
    <item>
      <title>Correction: Corrected: Prostamax</title>
      <link>https://greypeptides.com/corrections/#c-q1008-prostamax-citation</link>
      <guid isPermaLink="false">greypeptides-changes-prostamax-corr-c-q1008-prostamax-citation</guid>
      <pubDate>Fri, 30 Oct 2026 12:00:00 +0000</pubDate>
      <category>Correction</category>
      <description>The unfindable citation and the Prostagen alias are gone. The six indexed papers that name it study chromatin in white blood cells from people aged 75 to 88 and rat tissue explants; none gave it to people.</description>
    </item>
    <item>
      <title>Regulatory alert: US FDA: FDA warned a Florida online peptide seller that two products it sold, gonadorelin and one sold as Prostamax, are unapproved new drugs. Posted July 16.</title>
      <link>https://greypeptides.com/regulatory/alerts/#fda-wl-florida-seller-gonadorelin</link>
      <guid isPermaLink="false">greypeptides-changes-prostamax-alert-fda-wl-florida-seller-gonadorelin</guid>
      <pubDate>Wed, 17 Jun 2026 12:00:00 +0000</pubDate>
      <category>Regulatory alert</category>
      <description>Another letter that looks past 'research use only' and 'not for human consumption' labelling to what the website shows.</description>
    </item>
  </channel>
</rss>
